3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
15
Triple Negative Breast Neoplasms
5
Ovarian Neoplasms
4
Prostatic Neoplasms
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Multiple Myeloma
2
Locally Advanced (Inoperable) or Metastatic Breast Cancer
2
Leukemia
2
Hematologic Neoplasms
2
Healthy Participants
2
Disease Progression
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Moderate Hepatic Impairment
1
Interventions
Nivolumab
6
Ipilimumab
2
Gemcitabine
2
zaleplon
1
temsirolimus
1
relatlimab
1
regorafenib
1
olaparib
1
linrodostat
1
Vorinostat
1
Trastuzumab
1
Standard of Care
1
Sirolimus
1
Rehabilitation
1
Psychotherapy
1
Paclitaxel
1
Oxaliplatin
1
Niacin
1
IFL protocol
1
Health Services Needs and Demand
1
Everolimus
1
Clinical Trials, Phase IV as Topic
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Cancer
×
capivasertib
×
1 year
×
Clear all
No trials found.